Skip to content

Intraovarian PRP & Gh in poor ovarian responder

The effects of intraovarian platelet rich plasma and growth hormone injection on infertile women with poor ovarian response

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20091012002576N32
Enrollment
60
Registered
2023-09-05
Start date
2023-09-23
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female infertility of other origin. Female infertility of other origin

Interventions

Intervention 1: Intervention group: Gh and platelet reach plasma that is prepared from patient s peripheral blood and injected in the ovarian tissue by transvaginal ultrasonographic guidance at the d

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Age 20-40 years old with abnormal ovarian reserve test. Antral follicle count<5. At least one previous IVF cycle <3oocyte was retrieved.

Exclusion criteria

Exclusion criteria: Ovarian insufficiency due to gonadal dysgenesia and abnormality of chromosoms Male infertility

Design outcomes

Primary

MeasureTime frame
Chemical pregnancy. Timepoint: Two weeks after fetal transfer. Method of measurement: Beta HCG test.;AMH. Timepoint: before and 3 months after intervention. Method of measurement: Measurements blood levels of AMH by Eliza method.

Secondary

MeasureTime frame
Clinical pregnancy. Timepoint: Four weeks after embryo transfer. Method of measurement: Heart beat activity in transvaginal sonogram.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Davari Tanha

Tehran University of Medical Sciences

Fatedavtanha@gmail.com+98 21 8880 0115

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026